Long-term follow up Helicobacter Pylori reinfection rate after second-line treatment: bismuth-containing quadruple therapy versus moxifloxacin-based triple therapy

被引：0
|
作者：
Min Soo Kim
Nayoung Kim
Sung Eun Kim
Hyun Jin Jo
Cheol Min Shin
Young Soo Park
Dong Ho Lee
机构：
[1] Seoul National University Bundang Hospital,Department of Internal Medicine
[2] Seoul National University College of Medicine,Department of Internal Medicine and Liver Research Institute
来源：
BMC Gastroenterology | / 13卷
关键词：
Reinfection; Quadruple; Moxifloxacin; Second-line;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Efficacy of 7-Day and 14-Day Bismuth-Containing Quadruple Therapy and 7-Day and 14-Day Moxifloxacin-Based Triple Therapy as Second-Line Eradication for Helicobacter pylori Infection
    Lee, Seong Tae
    Lee, Dong Ho
    Lim, Ji Hyun
    Kim, Nayoung
    Park, Young Soo
    Shin, Cheol Min
    Jo, Hyun Jin
    Song, In Sung
    GUT AND LIVER, 2015, 9 (04) : 478 - 485
  • [22] Second-line treatment for helicobacter pylori infection: 10-day moxifloxacin-based triple therapy vs. 2-week quadruple therapy
    Kang, Jung Mook
    Kim, Nayoung
    Lee, Dong Ho
    Park, Young Su
    Kim, Yu Rim
    Kim, Joo Sung
    Jung, Hyun Chae
    Song, In Sung
    GASTROENTEROLOGY, 2008, 134 (04) : A331 - A331
  • [23] Bismuth-Containing Quadruple Therapy as Second-Line Treatment for Helicobacter pylori Infection: Effect of Treatment Duration and Antibiotic Resistance on the Eradication Rate in Korea
    Lee, Byoung Hwan
    Kim, Nayoung
    Hwang, Tae Jun
    Lee, Sang Hyub
    Park, Young Soo
    Hwang, Jin-Hyeok
    Kim, Jin-Wook
    Jeong, Sook-Hyang
    Lee, Dong Hoo
    Jung, Hyun Chae
    Song, In Sung
    HELICOBACTER, 2010, 15 (01) : 38 - 45
  • [24] SECOND-LINE HELICOBACTER PYLORI RESCUE THERAPY WITH MOXIFLOXACIN AFTER FAILURE OF STANDARD TRIPLE OR NON-BISMUTH QUADRUPLE TREATMENTS
    Gisbert, J. P.
    Romano, M.
    Molina-Infante, J.
    Lucendo, A. J.
    Medina, E.
    Modolell, I.
    Rodriguez-Tellez, M.
    Gomez, B.
    Barrio, J.
    Perona, M.
    Ortuno, J.
    Arino, I.
    Dominguez-Munoz, J. E.
    Perez-Aisa, A.
    Bermejo, F.
    Dominguez, J. L.
    Almela, P.
    Gomez-Camarero, J.
    Millastre, J.
    Martin-Noguero, E.
    Gravina, A. G.
    Martorano, M.
    Miranda, A.
    Federico, A.
    Fernandez-Bermejo, M.
    Angueira, T.
    Ferrer-Barcelo, L.
    Fernandez, N.
    Marin, A. C.
    McNicholl, A. G.
    HELICOBACTER, 2014, 19 : 136 - 137
  • [25] RECENT ERADICATON RATE OF MOXIFLOXACIN-CONTAINING TRIPLE THERAPY AS SECOND-LINE TREATMENT FOR HELICOBACTER PYLORI IN KOREA
    Lee, S.
    Lim, J.
    Lee, D.
    Seol, S.
    Kim, N.
    Park, Y.
    Shin, C.
    Cho, H.
    HELICOBACTER, 2012, 17 : 118 - 118
  • [26] THE EFFECT OF MOXIFLOXACIN CONTAINING TRIPLE THERAPY AS SECOND-LINE TREATMENT FOR HELICOBACTER PYLORI ERADICATION INFECTION
    Hwang, J.
    Lee, D.
    Yoon, K.
    Lee, H.
    Jeong, Y.
    Kwon, Y.
    Lee, A.
    Yoon, H.
    Shin, C.
    Park, Y.
    Kim, N.
    Seol, S.
    Jung, H.
    HELICOBACTER, 2014, 19 : 139 - 139
  • [27] Modified quadruple therapy or bismuth-containing quadruple therapy in the first-line treatment of Helicobacter pylori in Turkey
    Yozgat, Ahmet
    Kasapoglu, Benan
    Demirci, Selim
    Sokmen, Fevzi Coskun
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2021, 113 (07) : 490 - 493
  • [28] The efficacy of 10 day-triple therapy-based, bismuth-containing quadruple therapy for the first line therapy of Helicobacter pylori
    Moon, B. S.
    Yi, S. W.
    Lim, H. C.
    Lee, Y. C.
    HELICOBACTER, 2018, 23
  • [29] The efficacy of moxifloxacin-based triple therapy as second-line H. pylori eradication regimen
    Lee, Seunghyun
    Choi, Jae Won
    Oh, Myungjin
    Park, Junggil
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 229 - 230
  • [30] Helicobacter pylori First-Line Treatment With Bismuth-Containing Quadruple Therapy, and Second-Line Levofloxacin-Based Rescue Option, in Patients Allergic to Penicillin
    Gisbert, Javier P.
    Barrio, Jesus
    Modolell, Ines
    Molina-Infante, Javier
    Aisa, Angeles Perez
    Gisbert, JoseLuis
    Bermejo, Miguel Fernandez
    Marcos, Santiago
    GASTROENTEROLOGY, 2014, 146 (05) : S393 - S393
12345